Not checked for notices yet.

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer

Mohammadreza Azangou-Khyavy, Mobina Ghasemi, Javad Khanali and 5 more

Frontiers in Immunology · 2020

doi:10.3389/fimmu.2020.02062

Cited by papers we hold 2

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy · 2024
Corrected
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response · 2022
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.